Related Experiment Video
Updated: Dec 3, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Changes in antidepressant therapy should be considered early in patients with inadequate response to a first-line
Bernhard T Baune1,2,3, Peter Falkai4
1Department of Psychiatry and Psychotherapy, University of Münster, Münster, Germany.
Abstract:
Deciding when and how to change treatment in patients with major depressive disorder who have inadequate response to initial antidepressant therapy is an important everyday clinical question. Here, we ask whether an early change of approach is superior to a delayed change. We consider the recommendations provided by recent guidelines, examine the evidence behind this guidance and suggest a decision tree to clarify treatment options and timing. Both the early and late-change strategies may have their place in clinical practice. However, we take the view that an earlier than currently usual change in antidepressant treatment should be considered more frequently in cases of non-response. Specific studies are needed to identify and to better understand predictors of early and late response.
Insights
For major depressive disorder, changing antidepressant treatment sooner rather than later may improve outcomes for non-responsive patients. Further research is needed to identify predictors of treatment response.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Managing major depressive disorder (MDD) requires effective treatment strategies.
- Inadequate response to initial antidepressant therapy is common.
- Clinical decisions regarding treatment changes are crucial.
Purpose of the Study:
- To evaluate whether an early change in antidepressant treatment is superior to a delayed change in patients with MDD and inadequate response.
- To provide guidance on treatment options and timing for MDD management.
Main Methods:
- Review of recent clinical guidelines for MDD treatment.
- Examination of evidence supporting current treatment change recommendations.
- Development of a decision tree for clinical practice.
Main Results:
- Both early and delayed treatment change strategies have potential clinical utility.
- Current practices may delay treatment changes more than optimal in non-responsive cases.
- Evidence suggests earlier intervention could be beneficial.
Conclusions:
- An earlier change in antidepressant treatment should be more frequently considered for patients with MDD who show non-response.
- Further research is necessary to identify predictors of early and late treatment response in MDD.
- Optimizing treatment timing is key for improving patient outcomes in major depressive disorder.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Desensitization and Tachyphylaxis

